Compare, Analyse ALEMBIC PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
ALEMBIC PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs664349-   
Low Rs412252-   
Sales per share (Unadj.) Rs208.7103.7-  
Earnings per share (Unadj.) Rs31.0-26.1-  
Cash flow per share (Unadj.) Rs37.1-21.7-  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.281.4-  
Shares outstanding (eoy) m188.52168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.62.9 89.1%   
Avg P/E ratio x17.4-11.5 -151.2%  
P/CF ratio (eoy) x14.5-13.9 -104.7%  
Price / Book Value ratio x3.73.7 101.2%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46150,658 200.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m7,4673,179 234.9%   
Avg. sales/employee Rs ThNM4,078.4-  
Avg. wages/employee Rs ThNM740.6-  
Avg. net profit/employee Rs ThNM-1,027.7-  
INCOME DATA
Net Sales Rs m39,34717,508 224.7%  
Other income Rs m94123 76.5%   
Total revenues Rs m39,44117,631 223.7%   
Gross profit Rs m8,736-3,034 -287.9%  
Depreciation Rs m1,152756 152.5%   
Interest Rs m184474 38.8%   
Profit before tax Rs m7,493-4,141 -180.9%   
Minority Interest Rs m11-12 -93.6%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568259 605.7%   
Profit after tax Rs m5,844-4,412 -132.5%  
Gross profit margin %22.2-17.3 -128.1%  
Effective tax rate %20.9-6.2 -334.8%   
Net profit margin %14.9-25.2 -58.9%  
BALANCE SHEET DATA
Current assets Rs m19,57712,823 152.7%   
Current liabilities Rs m14,8967,215 206.5%   
Net working cap to sales %11.932.0 37.1%  
Current ratio x1.31.8 73.9%  
Inventory Days Days90111 80.9%  
Debtors Days Days45124 36.6%  
Net fixed assets Rs m27,0977,475 362.5%   
Share capital Rs m37781 463.8%   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,18813,742 197.8%   
Long term debt Rs m4,9934,829 103.4%   
Total assets Rs m47,77825,960 184.0%  
Interest coverage x41.7-7.7 -539.3%   
Debt to equity ratio x0.20.4 52.3%  
Sales to assets ratio x0.80.7 122.1%   
Return on assets %12.6-15.2 -83.2%  
Return on equity %21.5-32.1 -67.0%  
Return on capital %23.6-19.8 -119.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,1201,494 543.3%  
From Investments Rs m-7,556-459 1,646.6%  
From Financial Activity Rs m5904,383 13.5%  
Net Cashflow Rs m1,1535,418 21.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.81 Rs / ZAR

Compare ALEMBIC PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: GLENMARK PHARMA  CIPLA  WYETH LTD  ELDER PHARMA  JUBILANT LIFE SCIENCES  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views On News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Oct 16, 2019 03:37 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS